|
FTSJ2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.638600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.428000E-01 |
| Normal-vs-Stage2 |
1.254600E-01 |
| Normal-vs-Stage3 |
1.233620E-01 |
| Normal-vs-Stage4 |
2.002100E-02 |
| Stage1-vs-Stage2 |
1.277660E-02 |
| Stage1-vs-Stage3 |
1.751240E-01 |
| Stage1-vs-Stage4 |
2.634300E-02 |
| Stage2-vs-Stage3 |
2.675700E-03 |
| Stage2-vs-Stage4 |
1.020870E-03 |
| Stage3-vs-Stage4 |
2.831400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.195400E-01 |
| Normal-vs-AfricanAmerican |
6.104600E-01 |
| Normal-vs-Asian |
4.521200E-01 |
| Caucasian-vs-AfricanAmerican |
8.147800E-01 |
| Caucasian-vs-Asian |
7.428000E-02 |
| AfricanAmerican-vs-Asian |
3.020000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.700800E-01 |
| Normal-vs-Female |
2.827200E-01 |
| Male-vs-Female |
4.026400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.122600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.723800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.249200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.212220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.953600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.419800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.384600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.887800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.912200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.537600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.598200E-04 |
| Classical-VS-Follicular |
5.905800E-01 |
| Classical-VS-Other |
2.849200E-01 |
| Classical-VS-Normal |
6.657800E-01 |
| Tall-VS-Follicular |
1.299600E-03 |
| Tall-VS-Other |
6.455000E-01 |
| Tall-VS-Normal |
1.543290E-03 |
| Follicular-VS-Other |
3.201400E-01 |
| Follicular-VS-Normal |
9.342800E-01 |
| Other-VS-Normal |
1.865430E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.005400E-01 |
| Normal-vs-N1 |
3.374300E-02 |
| N0-vs-N1 |
5.080000E-03 |
|
|
